We create robust drug delivery systems

Hands-on, expert CMC support for advanced drug products—from concept to submission

We solve challenges in drug product development

Our aim is to support clients in understanding the critical factors and developing robust dosage forms. From years of experience, our team has developed a systematic approach backed by profound knowledge of excipients, equipment, processes, and documentation. Our expertise extends beyond solid dosage forms like softgel capsules and tablets to encompass advanced delivery systems for oral, pulmonary, and local applications.

Discover our focus areas

Our independent expertise bridges the gap in softgel capsules, from concept to documentation.

Our experience with hard capsules/tablets enables us to identify critical problems clearly and efficiently, solveing them with ease.

We are introducing pharmaceutical expertise into the medicinal cannabis field by providing valuable insights.

 Bringing formulation and drug product expertise to the forefront, we understand the intricacies of your product and can enhance your analytical development.

Why work with us? 

Bringing years of combined development experience and a track record of successfully registering numerous products in the EU and USA, we offer efficient CMC project management and development expertise to the pharmaceutical industry.

Comprehensive approach to CMC activities

We handle every aspect of developing solid dosage forms—from formulation to regulatory documentation—using a structured and systematic approach.

Complex problems, solved with ease

With solid technological background, we design development programs to reach profound understanding of critical factors. Considering ICH Q8 requirements, we apply a systematic and risk-based approach to formulation and process development.

Core expertise in advanced solid formulations

We bring outstanding technical expertise in soft capsules, single and multiple unit solid drug delivery systems for efficient development of advanced drug products.

  • “The Trias Pharma team skillfully navigated our various CDMOs and demonstrated adept management capabilities throughout. Their integral involvement in preparing our IND documentation and guiding our regulatory strategy significantly contributed to securing a positive FDA outcome. The team demonstrated true dedication to our project as if it were their own, playing a vital role in our team’s achievements.”

    Mike Harris, CEO of Biocomposites Ltd.

About us

Trias Pharma emerged from our collective passion for tackling challenges in drug product development. Drawing on more than 3 decades of experience in pharmaceutical development for our valued clients, we recognize the vital significance of meticulous attention to detail and comprehensive documentation. Our fulfillment lies in guiding clients toward a deeper understanding and the streamlined development of resilient drug products.

Tell us about your project

Schedule a call with us and find out how we can help